speaker
Lateef Shahbazian
Conference Operator

Good afternoon. Thank you for standing by. Welcome to the Westlake Chemical Partners second quarter 2022 earnings conference call. During the presentation, all participants will be in a listen-only mode. After the speaker's remarks, you will be invited to participate in the question and answer session. As a reminder, this conference is being recorded today, August 2nd, 2022. I would now like to turn the call over to today's host, Jeff Holly, Westlake Chemical Partners Vice President and Treasurer. Sir, you may begin.

speaker
Jeff Holly
Vice President and Treasurer, Westlake Chemical Partners

Thank you, Lateef. Good afternoon, everyone, and welcome to the Westlake Chemical Partners second quarter 2022 conference call. I'm joined today by Albert Chow, our President and CEO, Steve Bender, our Executive Vice President and CFO, and other members of our management team. During this call, we refer to ourselves as Westlake Partners or the Partnership, References to Westlake refer to our parent company, Westlake Corporation, and references to Opco refer to Westlake Chemical Opco LP, a subsidiary of Westlake and the partnership, which owns certain Oliphant assets. Additionally, when we refer to distributable cash flow, we are referring to Westlake Chemical Partners MLP distributable cash flow. Today, management is going to discuss certain topics that will contain forward-looking information that is based on management's beliefs, as well as assumptions made by, and information currently available to management. These forward-looking statements suggest predictions or expectations and thus are subject to risks or uncertainties. We encourage you to learn more about these factors that could lead our actual results to differ by reviewing the cautionary statements in our regulatory filings, which are also available on our investor relations website. This morning, Westlake Partners issued a press release with details of our second quarter 2022 financial and operating results. This document is available in the press release section of our webpage at wlkpartners.com. A replay of today's call will be available beginning two hours after the conclusion of this call. the replay via the partnership website. Please note that information reported on this call speaks only as of today, August 2nd, 2022, and therefore you are advised that time-sensitive information may no longer be accurate as of the time of any replay. I would finally advise you that this conference call is being broadcast live through an internet webcast system that can be accessed on our webpage at wlkpartners.com. Now, I would like to turn the call over to Albert Chao. Albert?

speaker
Albert Chow
President and CEO, Westlake Chemical Partners

Thank you, Jeff. Good afternoon, everyone, and thank you for joining us to discuss our second quarter 2022 results. In this morning's press release, we reported Westlake Partners' second quarter 2022 net income of $16 million, or 47 cents per unit. Westlake OPCO benefited from strong operating performance in the second quarter across all of our ethylene units, which when paired with favorable third-party ethylene sales margins drove consolidated net income, including OPCOs, of $84 million for the second quarter of 2022. The stability of Westlake Partners' business model is consistently demonstrated through our fixed-margin ethylene sales agreement, which minimizes market volatility and other production risks. The high degree of stability in cash flow when compared with the predictability of our business has enabled us to deliver the long history of reliable distributions and coverage. This quarter's distribution is the 32nd consecutive quarterly distribution since our IPO. I would now like to turn our call over to Steve to provide more detail on the financial and operating results for the quarter. Steve?

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-